title: Respiratory syncytial virus-mediated NF-kappa B p65 phosphorylation at serine 536 is dependent on RIG-I, TRAF6, and IKK beta.
abstract: Respiratory syncytial virus (RSV) is the etiological agent of acute respiratory diseases, such as bronchiolitis and pneumonia. The exacerbated production of proinflammatory cytokines and chemokines in the airways in response to RSV is an important pillar in the development of these pathologies. As such, a keen understanding of the mechanisms that modulate the inflammatory response during RSV infection is of pivotal importance to developing effective treatment. The NF-kappaB transcription factor is a major regulator of proinflammatory cytokine and chemokine genes. However, RSV-mediated activation of NF-kappaB is far from characterized. We recently demonstrated that aside from the well-characterized IkappaBalpha phosphorylation and degradation, the phosphorylation of p65 at Ser536 is an essential event regulating the RSV-mediated NF-kappaB-dependent promoter transactivation. In the present study, using small interfering RNA and pharmacological inhibitors, we now demonstrate that RSV sensing by the RIG-I cytoplasmic receptor triggers a signaling cascade involving the MAVS and TRAF6 adaptors that ultimately leads to p65ser536 phosphorylation by the IKKbeta kinase. In a previous study, we highlighted a critical role of the NOX2-containing NADPH oxidase enzyme as an upstream regulator of both the IkappaBalphaSer32 and p65Ser536 in human airway epithelial cells. Here, we demonstrate that inhibition of NOX2 significantly decreases IKKbeta activation. Taken together, our data identify a new RIG-I/MAVS/TRAF6/IKKbeta/p65Ser536 pathway placed under the control of NOX2, thus characterizing a novel regulatory pathway involved in NF-kappaB-driven proinflammatory response in the context of RSV infection.
authors.affiliation: Centre de recherche du CHUM-Hôpital St Luc, 264 René Levesque-Est, PEA 311, Montréal, Quebec H2X 1P1, Canada.
authors.forename: Fabrice
authors.initials: F
authors.lastname: Yoboua
authors.forename: Alexis
authors.initials: A
authors.lastname: Martel
authors.forename: Annick
authors.initials: A
authors.lastname: Duval
authors.forename: Espérance
authors.initials: E
authors.lastname: Mukawera
authors.forename: Nathalie
authors.initials: N
authors.lastname: Grandvaux
mesh_terms: D000818:Animals; D002460:Cell Line; D000071457:DEAD Box Protein 58; D053487:DEAD-box RNA Helicases / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D051550:I-kappa B Kinase / Q000235:genetics / Q000378:metabolism*; D008562:Membrane Glycoproteins / Q000235:genetics / Q000378:metabolism*; D000074662:NADPH Oxidase 2; D019255:NADPH Oxidases / Q000235:genetics / Q000378:metabolism*; D010766:Phosphorylation; D034741:RNA, Small Interfering / Q000235:genetics / Q000378:metabolism; D012367:RNA, Viral / Q000235:genetics / Q000378:metabolism; D011971:Receptors, Immunologic; D012136:Respiratory Syncytial Viruses / Q000502:physiology*; D012694:Serine / Q000378:metabolism*; D015398:Signal Transduction; D048029:TNF Receptor-Associated Factor 6 / Q000235:genetics / Q000378:metabolism*; D051996:Transcription Factor RelA / Q000235:genetics / Q000378:metabolism*; D014779:Virus Replication
chemical_list: D008562:Membrane Glycoproteins; D034741:RNA, Small Interfering; D012367:RNA, Viral; D011971:Receptors, Immunologic; D048029:TNF Receptor-Associated Factor 6; D051996:Transcription Factor RelA; D012694:Serine; C056558:CYBB protein, human; D000074662:NADPH Oxidase 2; D019255:NADPH Oxidases; D051550:I-kappa B Kinase; C452820:RIGI protein, human; D000071457:DEAD Box Protein 58; D053487:DEAD-box RNA Helicases
references.citation: J Virol. 2009 Apr;83(8):3420-8
references.pmid: 19193783
references.citation: J Infect Dis. 1997 Mar;175(3):497-504
references.pmid: 9041319
references.citation: J Immunol. 2008 May 15;180(10):6911-22
references.pmid: 18453612
references.citation: Am J Respir Cell Mol Biol. 1995 Aug;13(2):237-44
references.pmid: 7626291
references.citation: J Virol. 1998 Jul;72(7):5610-8
references.pmid: 9621019
references.citation: J Virol. 2009 Oct;83(20):10605-15
references.pmid: 19706715
references.citation: J Virol. 2004 Mar;78(5):2232-41
references.pmid: 14963119
references.citation: J Virol. 2007 Feb;81(3):1401-11
references.pmid: 17108032
references.citation: Cell. 2008 Feb 8;132(3):344-62
references.pmid: 18267068
references.citation: J Mol Cell Biol. 2010 Jun;2(3):110-2
references.pmid: 20022884
references.citation: J Biol Chem. 2004 Jun 18;279(25):26115-25
references.pmid: 15073170
references.citation: J Biol Chem. 1999 Oct 22;274(43):30353-6
references.pmid: 10521409
references.citation: Mol Cell Biol. 2005 Nov;25(22):9806-19
references.pmid: 16260598
references.citation: Immunity. 2008 May;28(5):651-61
references.pmid: 18439848
references.citation: J Biol Chem. 2006 May 12;281(19):13275-13284
references.pmid: 16513650
references.citation: J Virol. 2008 Jan;82(1):335-45
references.pmid: 17942531
references.citation: J Virol. 1998 Jun;72(6):4756-64
references.pmid: 9573240
references.citation: Exp Lung Res. 2004 Jan-Feb;30(1):43-57
references.pmid: 14967603
references.citation: J Leukoc Biol. 1999 Mar;65(3):291-8
references.pmid: 10080530
references.citation: FEBS Lett. 2010 Feb 5;584(3):525-30
references.pmid: 19958770
references.citation: FASEB J. 2005 Apr;19(6):620-2
references.pmid: 15670977
references.citation: Chembiochem. 2004 Oct 4;5(10):1348-58
references.pmid: 15457532
references.citation: Mol Cell. 2005 Sep 16;19(6):727-40
references.pmid: 16153868
references.citation: Ann N Y Acad Sci. 2008 Nov;1143:1-20
references.pmid: 19076341
references.citation: Cell Microbiol. 2003 Oct;5(10):671-80
references.pmid: 12969373
references.citation: Pharmacol Ther. 2009 Nov;124(2):219-34
references.pmid: 19615405
references.citation: J Biol Chem. 2004 Dec 31;279(53):55633-43
references.pmid: 15489227
references.citation: J Biol Chem. 2003 Mar 14;278(11):9441-7
references.pmid: 12524442
references.citation: FEBS J. 2005 Jun;272(12):3120-31
references.pmid: 15955070
references.citation: J Immunol. 2006 Dec 15;177(12):8676-83
references.pmid: 17142768
references.citation: Nat Immunol. 2009 Dec;10(12):1300-8
references.pmid: 19881509
references.citation: PLoS One. 2009 May 25;4(5):e5674
references.pmid: 19479062
references.citation: Am J Respir Cell Mol Biol. 2000 Nov;23(5):581-5
references.pmid: 11062135
references.citation: J Virol. 1998 Jun;72(6):4849-57
references.pmid: 9573251
references.citation: Mol Cell Biol. 2003 Nov;23(21):7780-93
references.pmid: 14560022
references.citation: Cell. 2005 Sep 9;122(5):669-82
references.pmid: 16125763
references.citation: J Biol Chem. 2008 Dec 26;283(52):36211-20
references.pmid: 18984593
references.citation: J Biol Chem. 2001 Jun 8;276(23):19715-22
references.pmid: 11259439
references.citation: Trends Biochem Sci. 2001 Mar;26(3):186-90
references.pmid: 11246025
references.citation: Microbes Infect. 2006 Jul;8(8):2013-20
references.pmid: 16797201
references.citation: J Biol Chem. 2004 Feb 27;279(9):7799-806
references.pmid: 14676197
references.citation: J Biol Chem. 2003 Jan 10;278(2):919-26
references.pmid: 12419817
references.citation: Annu Rev Immunol. 2009;27:693-733
references.pmid: 19302050
references.citation: J Virol. 2005 Jul;79(14):8948-59
references.pmid: 15994789
references.citation: Eur Respir J. 2002 Feb;19(2):350-5
references.pmid: 11871367
references.citation: EMBO J. 2006 Jul 26;25(14):3257-63
references.pmid: 16858409
references.citation: J Virol. 2002 Jun;76(11):5532-9
references.pmid: 11991981
references.citation: J Virol. 1996 Dec;70(12):8773-81
references.pmid: 8971006
references.citation: FASEB J. 2007 Sep;21(11):2642-54
references.pmid: 17431096
references.citation: J Biol Chem. 2009 Apr 17;284(16):10774-82
references.pmid: 19224920
references.citation: Nat Immunol. 2008 Dec;9(12):1364-70
references.pmid: 18997792
references.citation: J Biol Chem. 2007 Jun 15;282(24):17340-50
references.pmid: 17439942
references.citation: J Biol Chem. 2004 Jun 18;279(25):26243-50
references.pmid: 15084608
references.citation: Science. 2003 May 16;300(5622):1148-51
references.pmid: 12702806
references.citation: J Infect Dis. 2004 Apr 15;189(8):1419-30
references.pmid: 15073679
references.citation: Cell. 2002 Apr;109 Suppl:S81-96
references.pmid: 11983155
references.citation: J Virol. 1999 May;73(5):4502-7
references.pmid: 10196356
references.citation: Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1148-53
references.pmid: 15802625
references.citation: J Virol. 2001 Oct;75(19):9044-58
references.pmid: 11533168
references.citation: J Infect Dis. 2004 May 15;189(10):1856-65
references.pmid: 15122522
references.citation: J Immunol. 2006 Aug 15;177(4):2527-35
references.pmid: 16888014
references.citation: J Infect Dis. 2002 Nov 1;186(9):1199-206
references.pmid: 12402188
references.citation: Am J Respir Crit Care Med. 2000 May;161(5):1501-7
references.pmid: 10806145
references.citation: J Biol Chem. 2003 Sep 19;278(38):36916-23
references.pmid: 12842894
references.citation: J Infect Dis. 1996 Aug;174(2):262-7
references.pmid: 8699053
references.citation: Paediatr Respir Rev. 2004;5 Suppl A:S127-33
references.pmid: 14980257
references.citation: Biochem Pharmacol. 2006 Nov 30;72(11):1493-505
references.pmid: 16723122
references.citation: Microbes Infect. 2006 Jul;8(8):2138-44
references.pmid: 16782388
references.citation: Am J Physiol. 1997 Mar;272(3 Pt 1):L512-20
references.pmid: 9124609
references.citation: J Virol. 2009 Feb;83(3):1299-311
references.pmid: 19036819
references.citation: BMC Infect Dis. 2002 Mar 28;2:5
references.pmid: 11922866